Literature DB >> 17057750

An approach to the patient with late-onset cerebellar ataxia.

Brent L Fogel1, Susan Perlman.   

Abstract

BACKGROUND: An 83-year-old man presented with hypertension, hyperlipidemia, and a previous basal cell carcinoma, having developed progressive worsening of his balance and difficulty walking at the age of 78 years. He was initially diagnosed with stroke, but MRI revealed only isolated cerebellar atrophy. The patient then underwent multiple evaluations for an underlying paraneoplastic process, all of which were negative, but his symptoms progressed and he remained undiagnosed for several years. INVESTIGATIONS: Neurological examination, laboratory blood tests, MRI, and directed genetic testing. DIAGNOSIS: Five years after becoming symptomatic, the patient was re-evaluated for a possible genetic ataxia syndrome, which was subsequently confirmed by gene testing as spinocerebellar ataxia type 6 (SCA6). MANAGEMENT: Symptomatic medical treatment and physical, occupational, and speech therapy.

Entities:  

Mesh:

Year:  2006        PMID: 17057750     DOI: 10.1038/ncpneuro0319

Source DB:  PubMed          Journal:  Nat Clin Pract Neurol        ISSN: 1745-834X


  22 in total

1.  Mutations in rare ataxia genes are uncommon causes of sporadic cerebellar ataxia.

Authors:  Brent L Fogel; Ji Yong Lee; Jessica Lane; Amanda Wahnich; Sandy Chan; Alden Huang; Greg E Osborn; Eric Klein; Catherine Mamah; Susan Perlman; Daniel H Geschwind; Giovanni Coppola
Journal:  Mov Disord       Date:  2012-01-27       Impact factor: 10.338

Review 2.  Clinical neurogenetics: autosomal dominant spinocerebellar ataxia.

Authors:  Vikram G Shakkottai; Brent L Fogel
Journal:  Neurol Clin       Date:  2013-07-30       Impact factor: 3.806

3.  Utilization of genetic testing prior to subspecialist referral for cerebellar ataxia.

Authors:  Brent L Fogel; Barbara G Vickrey; Jenny Walton-Wetzel; Eli Lieber; Carole H Browner
Journal:  Genet Test Mol Biomarkers       Date:  2013-06-01

4.  Oculomotor and visual axis systems sparing in spinocerebellar ataxia type 13(R420H).

Authors:  Michael F Waters; Sankarasubramoney H Subramony; Joel Advincula; Susan Perlman; Tetsuo Ashizawa
Journal:  Neurology       Date:  2012-08-29       Impact factor: 9.910

5.  Very late-onset Friedreich ataxia: later than life expectancy?

Authors:  Vincent Alvarez; Pierre Arnold; Thierry Kuntzer
Journal:  J Neurol       Date:  2013-02-22       Impact factor: 4.849

6.  Interpretation of genetic testing: variants of unknown significance.

Authors:  Brent L Fogel
Journal:  Continuum (Minneap Minn)       Date:  2011-04

Review 7.  An Overview of the Current State and the Future of Ataxia Treatments.

Authors:  Kimberly Tsu Kwei; Sheng-Han Kuo
Journal:  Neurol Clin       Date:  2020-02-27       Impact factor: 3.806

8.  Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia.

Authors:  Brent L Fogel; Hane Lee; Joshua L Deignan; Samuel P Strom; Sibel Kantarci; Xizhe Wang; Fabiola Quintero-Rivera; Eric Vilain; Wayne W Grody; Susan Perlman; Daniel H Geschwind; Stanley F Nelson
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

9.  Low-Titre GAD Antibody-Associated Late-Onset Cerebellar Ataxia with a Significant Clinical Response to Intravenous Immunoglobulin Treatment.

Authors:  Timotej Petrijan; Marija Menih
Journal:  Cerebellum       Date:  2017-08       Impact factor: 3.847

10.  A family with spinocerebellar ataxia type 5 found to have a novel missense mutation within a SPTBN2 spectrin repeat.

Authors:  Ellen Cho; Brent L Fogel
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.